Krishnankutty Sudhir

Showing 1-14 of 14 articles

Coronary interventions

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys PW

November 20, 2016 | 10.4244/EIJV12I10A206

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys PW

April 20, 2015 | 10.4244/EIJV10I12A243

Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy

Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E

July 26, 2013 | 10.4244/EIJV9I3A57

Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial

Yamasaki M, Tsujino I, Lima-Filho M, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone G, Waseda K, Honda Y, Fitzgerald P

October 26, 2012 | 10.4244/EIJV8I6A112

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

Kedhi E, Stone G, Kereiakes D, Serruys PW, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P

September 28, 2012 | 10.4244/EIJV8I5A92

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes

Morice M, Mikhail G, Mauri i Ferr F, Modena M, Strasser R, Grinfeld L, Sudhir K, Stuteville M, Papeleu P, Li D, Rutledge D, Windecker S

July 27, 2012 | 10.4244/EIJV8I3A51

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

Hermiller J, Sudhir K, Applegate R, Rizvi A, Wang J, Gordon P, Yaqub M, Cao S, Ferguson J, Smith R, Sood P, MPhil M, Stone G

May 15, 2012 | 10.4244/EIJV8I1A14

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

Applegate R, Hermiller J, Gordon P, Yaqub M, Sood P, Su X, Cao S, Sudhir K, Stone G

January 20, 2012 | 10.4244/EIJV7I9A165

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Hermiller J, Nikolsky E, Lansky A, Applegate R, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone G

July 29, 2011 | 10.4244/EIJV7I3A54

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys PW

April 20, 2011

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Lansky A, Yaqub M, Hermiller J, Smith R, Farhat N, Caputo R, Williams J, Sanz M, Koo K, Sood P, Sudhir K, Stone G

January 11, 2011

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial

Applegate R, Hermiller J, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky A, Sudhir K, Stone G

September 30, 2010

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

Okamura T, Garg S, Gutiérrez-Chico J-L, Shin E, Onuma Y, Garcia-Garcia H, Rapoza R, Sudhir K, Regar E, Serruys PW

April 12, 2010

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

Seth A, Serruys PW, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone G

February 25, 2010

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease